Understanding adverse events of immunotherapy: A mechanistic perspective is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: F31 AI147638
National Institutes of Health
Grant: T32 AI089443
National Institutes of Health
Grant: T32 HL116324
National Institutes of Health
Grant: P01 AI108545
National Institutes of Health
Grant: R01 DK089125
National Institutes of Health
Grant: P50 CA127003
NIAID NIH HHS
Grant: P01 AI039671
NIAID NIH HHS
Grant: P01 AI056299
National Institutes of Health
Grant: 5P01AI108545-08
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
National Institutes of Health
Grant: 1R01DK089125-01A1
Parameters that influence CD4+ T cell diabetogenic potential
National Institutes of Health
Grant: 2P50CA127003-11A1
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
National Institutes of Health
Grant: 5T32AI089443-03
Autoimmunity and Immunopathology Training Program
National Institutes of Health
Grant: 1F31AI147638-01
Investigating a disintegrin and metalloproteinase-mediated Neuropilin 1 cleavage in autoimmune diabetes
National Institutes of Health
Grant: 2T32HL116324-06
Training Program in Molecular Hematology
FWCI
1.90
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals